117 related articles for article (PubMed ID: 30601146)
1. Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.
Ryckman JM; Surkar SM; Haque W; Butler EB; Teh BS; Verma V
Am J Clin Oncol; 2019 Mar; 42(3):258-264. PubMed ID: 30601146
[TBL] [Abstract][Full Text] [Related]
2. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
3. Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):567-575. PubMed ID: 27401158
[TBL] [Abstract][Full Text] [Related]
4. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
Verma V; Allen PK; Simone CB; Gay HA; Lin SH
J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
[No Abstract] [Full Text] [Related]
5. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
Khan KA; Abbasi AN; Ali N
J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
[TBL] [Abstract][Full Text] [Related]
7. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
8. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.
Hyder DJ; Sung L; Pollack IF; Gilles FH; Yates AJ; Davis RL; Boyett JM; Finlay JL
J Neurooncol; 2007 May; 83(1):1-8. PubMed ID: 17252186
[TBL] [Abstract][Full Text] [Related]
10. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.
Cushman TR; Shaaban SG; Moreno AC; Lin C; Verma V
Am J Clin Oncol; 2019 Feb; 42(2):154-159. PubMed ID: 30499838
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
[TBL] [Abstract][Full Text] [Related]
12. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
[TBL] [Abstract][Full Text] [Related]
13. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
14. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
15. Clinicohistological study of oligodendroglioma and oligoastrocytoma.
Tamura M; Zama A; Kurihara H; Kano T; Imai H; Ishiuchi S; Iwai T; Naito I
Brain Tumor Pathol; 1997; 14(1):35-9. PubMed ID: 9384800
[TBL] [Abstract][Full Text] [Related]
16. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas.
Quon H; Abdulkarim B
Cochrane Database Syst Rev; 2008 Apr; (2):CD007104. PubMed ID: 18425979
[TBL] [Abstract][Full Text] [Related]
19. Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted).
Anderson MD; Gilbert MR
J Natl Compr Canc Netw; 2014 May; 12(5):665-72. PubMed ID: 24812135
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy Versus Chemotherapy Alone for Unresected Nonmetastatic Gallbladder Cancer: National Practice Patterns and Outcomes.
Verma V; Surkar SM; Brooks ED; Simone CB; Lin C
J Natl Compr Canc Netw; 2018 Jan; 16(1):59-65. PubMed ID: 29295882
[No Abstract] [Full Text] [Related]
[Next] [New Search]